t*****2
发帖数: 213 | 1 1. Clin Lymphoma Myeloma Leuk. 2011 Feb;11(1):118-20.
The bone marrow niche in Waldenström's macroglobulinemia.
2. Clin Lymphoma Myeloma Leuk. 2011 Feb;11(1):109-11.
Key role of microRNAs in Waldenström's macroglobulinemia pathogenesis.
Thank you |
|
W********1
发帖数: 35 | 2 都巿女性事業心重，一般都將生育計劃押後，認為35歲前生第一胎就可以，但最新一項
研究指出，原來女性甫過30歲，分娩的風險已較25至29歲增加20%。
瑞 典卡羅琳學院與卑爾根大學合作的一項研究分析瑞典及挪威100萬名首次分娩的孕婦
的資料，對比30至34歲孕婦與25至29歲孕婦的分娩狀況，發現前者超 級早產（懷孕22
至31周分娩）甚至胎死腹中的機率，較後者高出20%；如果孕婦是吸煙人士或過胖，風
險更與35至39歲的孕婦無異。
領導研究的Ulla Waldenström教授指出，生物學上，首次分娩的最佳時期是20至
30歲。研究刊於《婦產科》（Obstetrics and Gynecology）期刊。
〔轉載〕 |
|
发帖数: 1 | 3 J&J, AbbVie's Imbruvica breaks into larger CLL market with first-line FDA
nod
March 4, 2016
Johnson & Johnson and AbbVie have snagged the indication for standout cancer
med Imbruvica that they've been waiting for.
On Friday, the FDA granted the pair a first-line nod in chronic lymphocytic
leukemia (CLL) based on results of a Phase III trial in which the med cut
the risk of disease progression or death by 84% compared with chemo
treatment chlorambucil.
It's a win for the companies, which already ... 阅读全帖 |
|
